Skip to main content

Advertisement

SpringerLink
Log in

All-trans-retinoic acid increases cytotoxicity of 1-β-d-arabinofuranosylcytosine in NB4 cells

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

Clinically, the benefits of combining all-trans-retinoic acid (ATRA) with chemotherapy have been well documented in the treatment of acute promyelocytic leukemia (APL). Changes in nucleoside transporter expression and activity have been shown to occur in NB4 cells in vitro following treatment with ATRA. In this study we investigated whether ATRA treatment increases sensitivity to ara-C in NB4 cells. Specifically, we examined the role of ATRA-associated changes in nucleoside transporter expression and activity in eliciting ara-C cytotoxicity.

Methods

Cellular uptake of [3H]-ara-C and nucleoside transporter abundance were determined in untreated cells and cells treated with 1 μM ATRA for 12–72 h using an inhibitor and oil stop procedure, and an equilibrium [3H]-NBMPR binding assay, respectively. Cytotoxicity of ara-C and the apoptotic response prior to and following ATRA treatment were determined using the MTT viability assay and the TUNEL assay, respectively.

Results

ATRA treatment increased ara-C cytotoxicity and potency, ara-C transport, and augmented ara-C-induced apoptosis. The combination effect was supraadditive under some conditions and sequence-dependent whereby the maximum effect was seen when the addition of ATRA preceded the addition of ara-C, and when ara-C administration closely followed ATRA administration.

Conclusions

The ATRA-induced increase in cytotoxicity of ara-C was, in part, the result of an increase in the functional expression of nucleoside transporters, and a role for bcl-2 was also indicated. Our results would suggest that timing of ara-C therapy should be tied to maximal es transporter expression, which is likely to be 24 h after ATRA treatment begins. It remains to be seen whether the response in the clinic can be further enhanced in APL by taking advantage of ara-C transporter regulation by ATRA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1A, B.
Fig. 2A, B.
Fig. 3A, B.
Fig. 4A–C.
Fig. 5A–C.
Fig. 6A, B.
Fig. 7.

Similar content being viewed by others

References

  1. Alessi-Severini S, Gati WP, Belch AR, Paterson ARP (1995) Intracellular pharmacokinetics of 2-chlorodeoxyadenosine in leukemia cells from patients with chronic lymphocytic leukemia. Leukemia 9:1674

    CAS  PubMed  Google Scholar 

  2. Andreeff M, Jiang S, Zhang X, Konopleva M, Estrov Z, Snell VE, Xie Z, Okcu MF, Sanchez-Williams G, Dong J, Estey EH, Champlin RC, Komblau SM, Reed JC, Zhao S (1999) Expression of bcl-2 related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid. Leukemia 13:1881

    Article  CAS  PubMed  Google Scholar 

  3. Bardin C, Johnstone RM (1978) Sodium-dependent amino acid transport in reconstituted membrane vesicles from Ehrlich ascites cell plasma membranes. J Biol Chem 253:1723

    Google Scholar 

  4. Belt JA, Marina NM, Phelps DA, Crawford CR (1993) Nucleoside transport in normal and neoplastic cells. Adv Enzyme Regul 33:235

    Article  CAS  PubMed  Google Scholar 

  5. Berry DM, Williams K, Meckling-Gill KA (2000) All-trans-retinoic acid induces apoptosis in acute promyelocytic NB4 cells when combined with isoquinolinediol a poly(ADP-ribose) polymerase inhibitor. Leuk Res 24:307

    Article  CAS  PubMed  Google Scholar 

  6. Bocchia M, Xu Q, Wesley U, Xu Y, Korontsvit T, Loganzo F, Albino AP, Scheinberg DA (1997) Modulation of p53, WAF1/p21 and bcl-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells. Leuk Res 21:439

    Article  CAS  PubMed  Google Scholar 

  7. Boos J, Hohenlochter B, Schulze-Westhoff P (1996) Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia. Med Pediatr Oncol 26:397

    Article  CAS  PubMed  Google Scholar 

  8. Bradbury DA, Aldington S, Zhu Y-M, Russell NH (l996) Down-regulation of bcl-2 in AML blast by all-tans-retinoic acid and its relationship to CD34 antigen expression. Br J Haematol 94:671

    Google Scholar 

  9. Breitman TR, Selonick SE, Collins SJ (l980) Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci U S A 77:2936

    PubMed  Google Scholar 

  10. Breitman T, Collins S, Keene B (1981) Terminal differentiation of human promyelocytic leukemia cells in primary culture in response to retinoic acid. Blood 57:1000

    CAS  PubMed  Google Scholar 

  11. Burres NS, Cass CE (l986) Density-dependent inhibition of expression of syncytiotrophoblastic markers by cultured human choriocarcinomas (BeWo) cells. J Cell Physiol 128:375

    Google Scholar 

  12. Cai J, Lee CW (l996) Tamoxifen inhibits nitrobenzylthioinosine-sensitive equilibrative uridine transport in human MCF7 breast cancer cells. Biochem J 320:991

    Google Scholar 

  13. Cass CE (l995) Nucleoside transport. In: Georgoapadakou NH (ed) Drug transport in antimicrobial therapy and anticancer therapy. Marcel Dekker, New York, p 403

  14. Cass CE, Gaudette LA, Paterson AR (1974) Mediated transport of nucleosides in human erythrocytes: specific binding of the inhibitor nitrobenzylthioinosine to nucleoside transport sites in the erythrocyte membrane. Biochim Biophys Acta 345:1

    CAS  PubMed  Google Scholar 

  15. Cass CE, Yound JD, Baldwin SA (1998) Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem Cell Biol 76:761

    Article  CAS  PubMed  Google Scholar 

  16. Cass CE, Young JD, Baldwin SA, Cabrita MA, Graham KA, Griffiths M, Jennings LL, Mackey JR, Ng AM, Ritzel MW, Vickers MF, Yao SY (1998) Nucleoside transporters of mammalian cells. In: Amidon G, Sadee W (eds) Membrane transporters as drug targets. Plenum, New York

  17. Cass CE, Young JD, Baldwin SA, Cabrita MA, Graham KA, Griffiths M, Jennings LL, Mackey JR, Ng AM, Ritzel MW, Vickers MF, Yao SY (1999) Nucleoside transporters of mammalian cells. Pharm Biotechnol 12:313

    CAS  PubMed  Google Scholar 

  18. Castaigne S, Chomienne C, Daniel M, Berger R, Fenaux P, Degos L (1990) All- trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemias. I. Clinical results. Blood 76:1704

    CAS  PubMed  Google Scholar 

  19. Chan TC (1989) Augmentation of 1-beta-d-arabinofuranosylcytosine cytotoxicity in human tumor cells by inhibition of drug efflux. Cancer Res 49:2656

    CAS  PubMed  Google Scholar 

  20. Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L (1990) All trans-retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure function relationships. Blood 76:1710

    CAS  PubMed  Google Scholar 

  21. Dalton W, Ahearn M, McCredie K, Freidreich E, Stass S, Tujillo J (l988) HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 71:242

    Google Scholar 

  22. de The H, Lavau C, Marchio A, et al (1991) The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675

    PubMed  Google Scholar 

  23. Estey E (1996) Treatment of refractory AML. Leukemia 10:932

    CAS  PubMed  Google Scholar 

  24. Estey E, Plunkett W, Dixon DO (1987) Variables predicting response to high-dose cytosine arabinoside therapy with refractory acute leukemia. Leukemia 1:580

    CAS  PubMed  Google Scholar 

  25. Fenaux P, Chomienne C, Degos L (1997) Acute promyelocytic leukemia: biology and treatment. Semin Oncol 24:92

    Google Scholar 

  26. Fenaux P, Castaigne C, Chevret S, Sanz M, Dombret H, Ardhimbaud E (1999) A randomized comparison of all-trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 94:1192

    CAS  PubMed  Google Scholar 

  27. Fenaux P, Chomienne C, Degos L (2001) Treatment of acute promyelocytic leukemia. Best Pract Res Clin Haematol 14:153

    Article  CAS  PubMed  Google Scholar 

  28. Flanagan SA, Meckling-Gill KA (1997) Characterization of a novel Na+ dependent, guanosine-specific nitrobenzylthioinosine-sensitive transporter in acute promyelocytic leukemia cells .J Biol Chem 272:18026

    Article  CAS  PubMed  Google Scholar 

  29. Freud A, Boos J, Harkin S (1998) Augmentation of 1-β-d-arabinofuranosylcytosine (Ara-C) cytotoxicity in leukemia cells by coadministration with antisignalling drugs. Eur J Cancer 34:895

    Article  PubMed  Google Scholar 

  30. Freud A, Rossig C, Lanvers A, Gescher B, Hohenlochter H, Jurgens H, Boos J (1999) All-trans retinoic acid increases cytosine arabinoside cytotoxicity in HL-60 human leukemia cells in spite of decreased cellular ara-CTP accumulation. Ann Oncol 10:335

    Article  PubMed  Google Scholar 

  31. Furth JJ, Cohen SS (1968) Inhibition of mammalian DNA polymerase by the 5′-triphosphate of 1-beta-d-arabinofuranosylcytosine and the 5′-triphosphate of 9-beta-d-arabinofuranoyladenine. Cancer Res 28:2061

    CAS  PubMed  Google Scholar 

  32. Gandhi V, Nowak BJ, Keating MF, Plunkett W (1989) Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy. Blood 74:2070

    CAS  PubMed  Google Scholar 

  33. Gati WP, Paterson AR, Larratt LM, Turner R, Belch AR (1997) Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein. Blood 90:346

    CAS  PubMed  Google Scholar 

  34. Goh LB, Lee CW (1997) Reduction of equilibrative nitrobenzylthioinosine-sensitive nucleoside transporter in tamoxifen-treated MCF-7 cells: an oestrogen-reversible phenomenon. Biochem J 327:31

    CAS  PubMed  Google Scholar 

  35. Graham FC, Whitmore GF (1970) Studies in mouse L-cells on the incorporation of 1-beta-d-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-d-arabinofuranosylcytosine 5′-triphosphate. Cancer Res 30:2636

    CAS  PubMed  Google Scholar 

  36. Grant S (1998) Ara-C: cellular and molecular pharmacology. Adv Cancer Res 72:197

    CAS  PubMed  Google Scholar 

  37. Green DA, Jarvis SM (1996) Regulation of apoptosis by oncogenes. J Cell Biochem 60:33

    Article  CAS  PubMed  Google Scholar 

  38. Griffith DA, Jarvis SM (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286:153

    CAS  PubMed  Google Scholar 

  39. Gunji H, Kharbanda S, Kufe D (1991) Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-d-arabinofuranosylcytosine. Cancer Res 51:741

    CAS  PubMed  Google Scholar 

  40. Hamond JR (1994) Functional reconstitution of pharmacologically distinct subtypes of nucleoside transporters in liposomal membranes. J Pharmacol Exp Ther 271:906

    Google Scholar 

  41. Heinemann V, Hertel LW, Grindey GB, Plunkett W (1988) Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-beta-d-arabinofuransylcytosine. Cancer Res 48:4024

    CAS  PubMed  Google Scholar 

  42. Hu ZB, Minden MD, McCulloch EA (1995) Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the ara-C sensitivity of leukemic stem cells. Leukemia 9:1667

    CAS  PubMed  Google Scholar 

  43. Huang M, Yu Chen Y, Shu Rong C, Chai J, Lin Z, Gulong J, Wang Z (1988) Use of al-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567

    CAS  PubMed  Google Scholar 

  44. Iacoboni S, Plunkett W, Kantarjian H, et al (1986) High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis. J Clin Oncol 4:1079–1088

    CAS  PubMed  Google Scholar 

  45. Jamieson GP, Snook MB, Wiley JS (1990) Saturation of intracellular cytosine arabinoside triphosphate accumulation in human leukemic blast cells. Leuk Res 14:475

    CAS  PubMed  Google Scholar 

  46. Jarvis SM (1988) Adenosine transporters. In: Cooper DMF, Londos C (eds) Adenosine receptors. Alan R. Liss, New York, p 113

  47. Jarvis SM, Young JD (1987) Photoaffinity labeling of nucleoside transport peptides. Pharmacol Ther 32:339

    Article  CAS  PubMed  Google Scholar 

  48. Johnson PA, Johnstone RM (1982) Partial purification of amino acid transport systems in Ehrlich ascites tumor cell plasma membranes. Membr Biochem 4:189

    CAS  PubMed  Google Scholar 

  49. Kantarjian H, Estey E, Plunkett W (1986) Phase 1-2 clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia. Am J Med 81:387

    CAS  PubMed  Google Scholar 

  50. Kaufmann SH (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49:5870

    CAS  PubMed  Google Scholar 

  51. Kaufmann SH, Earnshaw WC (2000) Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256:42

    Article  CAS  PubMed  Google Scholar 

  52. Keith FJ, Bradbury DA, Zhu YM, Russel NH (1995) Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to ara-C. Leukemia 9:131

    CAS  PubMed  Google Scholar 

  53. Konopleva M, Tari AM, Estrov Z, Harris D, Xie Z, Zhao S, Lopex-Berestein G, Andreef M (2000) Liposomal bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins. Blood 95:3929

    CAS  PubMed  Google Scholar 

  54. Kornblau SM, Thall PF, Extrove Z, Walterscheld M, Patel S, Theriault A, Keating MJ, Kantarjian H, Estey E, Andreeff M (1999) The prognostic Impact of bcl-2 protein expression in acute myelogenous leukemia varies with cytogenetics. Clin Cancer Res 5:1758

    CAS  PubMed  Google Scholar 

  55. Kufe DW, Major PP, Egan EM, Beardsley GP (1980) Correlation of cytotoxicity with incorporation of ara-C into DNA. J Biol Chem 255:8997

    CAS  PubMed  Google Scholar 

  56. Kufe D, Spriggs D, Dgan EM, Munroe D (1984) Relationship among ara-CTP pools, formation of (ara-C) DNA, and cytotoxicity of human leukemia cells. Blood 64:54

    CAS  PubMed  Google Scholar 

  57. Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680

    PubMed  Google Scholar 

  58. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R (1991) NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080

    CAS  PubMed  Google Scholar 

  59. Lishner M, Curtis JE, Minkin S, McCulloch EA (1989) Interaction between retinoic acid and cytosine arabinoside affecting the blast cells of acute myeloblastic leukemia. Leukemia 3:784

    CAS  PubMed  Google Scholar 

  60. Mackey JR, Baldwin SA, Young JD, Cass CE (1998) Nucleoside transport and its significance for anticancer drug resistance. Drug Res Updates 1:310

    CAS  Google Scholar 

  61. Mani RS, Hammond JR, Jarjan, JMJ, Graham KA, Young JD, Baldwin SA, Cass CE (1998) Demonstration of equilibrative nucleoside transporter (hENT1 and hENT2) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconstitution in proteoliposomes. J Biol Chem 46:30818

    Article  Google Scholar 

  62. Manome Y, Weichselbaum RR, Kufe D, Fine HA (1993) Effect of bcl-2 on ionizing radiation and 1-beta-d-arabinofuranosylcytosine-induced internucleosomal DNA fragmentation and cell survival in human myeloid leukemia cells. Oncol Res 5:139

    Google Scholar 

  63. Miyashita T, Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151

    CAS  PubMed  Google Scholar 

  64. Paterson ARP, Cass CE (1986) Transport of nucleoside drugs in animal cells. In: Goldman ID (ed) Membrane transport of antineoplastic agents. Pergamon Press, Oxford, p 309

  65. Paterson ARP, Jakobs ES, Harley ER, Cass CE, Robins MJ (1983) Inhibitors of nucleoside transport as probes and drugs. In: Cheng YC, Goz B, Minkof M (eds) Development of target-oriented anticancer drugs. Raven, New York, p 41

  66. Paterson ARP, Harley ER, Cass CE (1984) Inward fluxes of adenosine in erythrocytes and cultured cells measured by a quenched-flow method. Biochem J 224:1001

    CAS  PubMed  Google Scholar 

  67. Peterson AJ, Brown RD, Gibson J, Pope B, Luo, XF, Schutz L, Wiley JS Joshua DE (1996) Nucleoside transporters, bcl-2 and apoptosis in CLL cells exposed to nucleoside analogues in vitro. Eur J Haematol 56:213

    CAS  PubMed  Google Scholar 

  68. Plagemann PGW, Wohlheuter RM, Woffendin C (1988) Nucleoside and nucleobase transport in animal cells. Biochim Biophys Acta 947:405

    CAS  PubMed  Google Scholar 

  69. Plunkett W, Iacoboni S, Estey E, et al (1985) Pharmacologically directed ara-C therapy for refractory leukemia. Semin Oncol 12 [2 Suppl 3]:20

  70. Porwit MacDonald A, Ivory K, Wilkinson S, Wheayley D, Wong L, Janossy G (1995) bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia. Leukemia 9:1191

    PubMed  Google Scholar 

  71. Powell BL, White JC, Gregory BW (1991) S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cells. Leukemia 5:598

    CAS  PubMed  Google Scholar 

  72. Rauchwerger DR, Firby PS, Hedley DW, Moore MJ (2000) Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity. Cancer Res 60:6075

    CAS  PubMed  Google Scholar 

  73. Roovers KI, Meckling-Gill KA (1996) Characterization of equilibrative and concentrative Na+-dependent (cif) nucleoside transport in acute promyelocytic leukemia NB4 cells. J Cell Physiol 166:593

    Article  CAS  PubMed  Google Scholar 

  74. Rustum YM (1978) Metabolism and intracellular retention of 1-beta-d-arabinofuransylcytosine as predictors of response of animal tumors. Cancer Res 38:543

    CAS  PubMed  Google Scholar 

  75. Rustum YM, Preisler HD (1979) Correlation between leukemic cell retention of 1-beta-d-arbinofuranosylcytosine 5′-triphosphate and response to therapy. Cancer Res 39:42

    CAS  PubMed  Google Scholar 

  76. Shewach DS, Plunkett W (1982) Correlation of cytotoxicity with total intracellular exposure to 9-beta-d-arabinofuranosyladenine 5′-triphosphate. Cancer Res 42:3637

    CAS  PubMed  Google Scholar 

  77. Sirotnak FM, Chello Pl, Dorick DM, Montgomery JA (1983) Specificity of systems mediating transport of adenosine, 9-beta-d-arabinofuransyl-2-fluoroadenine, and other purine nucleoside analogues in L1210 cells. Cancer Res 43:104

    CAS  PubMed  Google Scholar 

  78. Sousa A, Fernandes J, Ferreira G, Bernardo M, Conduta A, Costa I, Cruz E, Goncalves A, Monterio A, Nunes O, Ribeiro P, Rodrigues A, Sousa M, Veiga J, Gouveia J (1999) Short-term intensive consolidation therapy after all-trans-retinoic acid in acute promyelocytic leukemia. Am J Clin Oncol 22:294

    Article  CAS  PubMed  Google Scholar 

  79. Thorn JA, Jarvis SM (1996) Adenosine transporters. Gen Pharmacol 27:613

    CAS  PubMed  Google Scholar 

  80. Traut TW (1994) Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140:1

    CAS  PubMed  Google Scholar 

  81. Tsiftsoglou AS, Wong W, Housman DE (1983) Dexamethasone-sensitive and insensitive response during in vitro differentiation of Friend erythroleukemia cells. Biochim Biophys Acta 759:160

    CAS  PubMed  Google Scholar 

  82. Webb A, Cunningham D, Cotter FEA (1997) BCL-2 antisense therapy in patients with non-Hodgkin's lymphoma. Lancet 349:1137

    CAS  PubMed  Google Scholar 

  83. White JC, Rathmel JP, Capizzi RL (1987) Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells. J Clin Invest 79:380

    CAS  PubMed  Google Scholar 

  84. Wiley JS, Jones SP, Sawyer WH, Paterson ARP (1982) Cytosine arabinoside influx and nucleoside transporter sites in acute leukemia. J Clin Invest 69:479

    CAS  PubMed  Google Scholar 

  85. Wiley JS, Jones SP, Sawyer WH (1983) Cytosine arabinoside transport by human leukemic cells. Eur J Clin Oncol 19:1067

    CAS  Google Scholar 

  86. Wiley JS, Taupin J, Jamieson GP, Snook MB, Sawyer WH, Finch LR (1985) Cytosine arabinoside transport and metabolism in acute leukemia and T cell lymphoblastic lymphoma. J Clin Invest 75:632

    CAS  PubMed  Google Scholar 

  87. Wiley JS, Snook MB, Jamieson GP (1989) Nucleoside transport in acute leukemia and lymphoma: close relation to proliferative rate. Br J Haematol 71:203

    CAS  PubMed  Google Scholar 

  88. Wiley JS, Smith CL, Jamieson GP (1991) Transport of 2-deoxycoformycin in human leukemia and lymphoma cells. Biochem Pharmacol 42:708

    Article  CAS  PubMed  Google Scholar 

  89. Yang GS, Minden MD, McCulloch EA (1993) Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside. Leukemia 7:1012

    CAS  PubMed  Google Scholar 

  90. Yang JL, White JC, Capizzi RL (1990) Enhanced retention of cytosine arabinoside and its metabolites and synergistic cytotoxicity by sequential treatment with dipyridamole in L5178Y leukemia. Cancer Chemother Pharmacol 26:135

    CAS  PubMed  Google Scholar 

  91. Zuhlsdorf M, Vormoor J, Boos J (1997) Cytosine arabinoside resistance in childhood leukemias. Int J Pediatr Hematol Oncol 4:565

    Google Scholar 

Download references

Acknowledgement

We would like to thank Dr. Ming Cha for his technical assistance.

Author information

Authors and Affiliations

  1. Department of Human Biology and Nutritional Sciences, University of Guelph, Guelph, Ontario, N1G 2W1, Canada

    S. A. Flanagan & K. A. Meckling

Authors
  1. S. A. Flanagan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. A. Meckling
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. A. Meckling.

Additional information

The Natural Sciences Engineering Research Council of Canada and a Departmental Graduate Scholarship to S.A.F. supported this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flanagan, S.A., Meckling, K.A. All-trans-retinoic acid increases cytotoxicity of 1-β-d-arabinofuranosylcytosine in NB4 cells. Cancer Chemother Pharmacol 51, 363–375 (2003). https://doi.org/10.1007/s00280-002-0561-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-002-0561-0

Keywords

Search

Navigation